Central Drugs entered the industry of in 1993 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 4461100, which describes it as a . For further clarification, the SIC classifies this business under the code 5912 and described it as a . The business provides service to the B2C market.
To acquire more information, please contact Mihran Dermenjian, Owner by calling (818) 956-1577 during business hours. You can also write to the business’ Single Location at 730 South Central Avenue # 117, Glendale, California CA 91204. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Central Drugs |
| Representative: | Mihran Dermenjian, Owner |
| Place of Business: | 730 South Central Avenue # 117, Glendale, CA 91204 |
| Contact Number: | (818) 956-1577 |
| Type of Service: | |
| SIC Number: | 5912 |
| NAICS Number: | 4461100 |
| Locality: | Single Location |
| Market Type: | B2C (Business to Consumer) |
| Began: | 1993 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Central Drugs is a company operating from Los Angeles, California providing professional and relevant B2C variables. It was founded in 1993 and registered with the SIC code 5912 as , and with the NAICS code 4461100 as .
With a current employee count of 1 to 4, Central Drugs has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Mihran Dermenjian, Owner at (818) 956-1577 for related queries, or to locate its Single Location using the coordinates 34.137413,-118.257788.
The Single Location can also be found at the street address 730 South Central Avenue # 117 in Glendale, California 91204 and can be engaged online through the company website at , the company Twitter , and Facebook page .